drugset
Drugs / ATx08-001
last change Jul 2011 re-read 3 minutes ago

ATx08-001

Developed for
postherpetic neuralgia
Investigated by
Aestus Therapeutics · National Institute of Neurological Disorders and Stroke (NINDS) · Parallax Clinical Research, LLC · Symbiance, Inc

Trials 1

today NCT01318226 · Ph 2
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01318226 Mar → Jul 2011 postherpetic neuralgia Aestus Therapeutics Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ATx 08-001 “Placebo is identical in appearance to the ATx 08-001 tablet.” NCT01318226 ↗
1

NCT01318226 ↗
Route Oral “taken orally” NCT01318226 ↗